Researchers are initiating studies to determine whether psychedelic compounds, specifically those found in mushrooms, can alleviate persistent symptoms following a concussion. The investigation focuses on the potential of these substances to promote neuroplasticity and aid in brain recovery. Post-concussion syndrome affects a significant number of individuals, often leading to long-term cognitive and emotional difficulties. Current treatments are limited, prompting exploration of alternative therapies like psychedelics. The trials will assess the safety and efficacy of controlled psychedelic administration in patients experiencing ongoing concussion symptoms. Early research suggests potential benefits, but rigorous clinical testing is crucial to validate these findings and establish appropriate protocols. This research represents a novel approach to treating a common and debilitating condition.